Belzutifan is a super selective inhibitor for something called HIF-2α. It’s mainly used to treat RCC linked to a condition called VHL. It works by cutting down on the ‘starving’ signals tumors use.
You can find this drug in 40 mg tablets. The usual dose is 120 mg, taken just once a day. Each bottle has 90 of these tablets.
